New data presented at EuroPCR from the much debated ORBITA trial may provide some modest temporary lessening of the pain felt by interventional cardiologists in response to the initial negative ORBITA findings. But the pain relief is likely to be only temporary, and might even be fairly compared to a placebo effect, since the major ...
New ORBITA findings may offer modest symptomatic pain relief to interventional cardiologists
By Larry Husten
23 May 2018